—

Oscar Health Inc(OSCR)— 同类公司组

数据截至2026-11-17 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Oscar Health Inc的Closelook综合评分为57/100,在同类公司组内排名第5位(共5家)——组内评分最高的是Halozyme Therapeutics Inc(71/100)。

名称综合动量质量估值信号距52周高点
OSCR Oscar Health Inc57804871info22.5%
HALO Halozyme Therapeutics Inc71679449info28.4%
ONC BeOne Medicines AG66896829ok2.7%
REGN Regeneron Pharmaceuticals Inc65907347neutral4%
RIGL Rigel Pharmaceuticals Inc64808976info16.9%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-11-17

Quick answers

Oscar Health Inc在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Halozyme Therapeutics Inc (HALO)、BeOne Medicines AG (ONC)、Regeneron Pharmaceuticals Inc (REGN)、Rigel Pharmaceuticals Inc (RIGL)。

OSCR相对同类公司的评分如何?

Oscar Health Inc的综合评分为57/100,组内排名第5位(共5家),截至2026-11-17;组内最高综合评分为Halozyme Therapeutics Inc(71/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Healthcare Plans, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.